Alistair R. Grenfell is the President, Commercial Solutions at IQVIA Holdings Inc., a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. With more than 25 years of experience in healthcare data and analytics, Alistair has dedicated his career to empowering pharmaceutical, biotech, and medtech companies with actionable insights to optimize commercial performance. He joined IMS Health—a predecessor company to IQVIA—in 2000, initially focusing on sales and marketing strategies in Europe before expanding his leadership across North America and global markets. Throughout his tenure, Alistair has driven remarkable achievements, including the scaling of IQVIA's commercial offerings to generate billions in value for clients through innovative data platforms and AI-driven tools. He played a pivotal role in the post-merger integration of IMS Health and Quintiles, launching solutions like the Orchestrated Customer Engagement platform, which revolutionized sales force effectiveness and market access strategies. His efforts have consistently delivered double-digit growth in key segments, earning him recognition as a visionary leader in healthcare commercialization. In his current role, Alistair oversees a worldwide team of over 10,000 professionals, steering the development and delivery of end-to-end commercial solutions—from real-world data analytics and predictive modeling to consulting services that accelerate product launches and revenue growth. Passionate about harnessing emerging technologies like generative AI and machine learning, he continues to position IQVIA at the forefront of transforming healthcare commercial operations for a rapidly evolving industry.